Healthcare Global Diabetic Retinopathy Drug Market | Page 2

The global diabetic retinopathy drug market is segmented into type of drugs such
as intraocular steroid injection, avastin, lucentis and anti-vascular endothelial
growth factor (VEGF) drug. Among these segments, anti-vascular endothelial
growth factor (VEGF) drug segment is expected witness considerable growth
during the forecast period. The growth of the anti-vascular endothelial growth
factor (VEGF) drug segment can be attributed to its beneficiary features such as
better treatment and faster recovery. Additionally, increasing number of
incidence of proliferative diseases is likely to bolster the growth of this segment
over the forecast period.
Global diabetic retinopathy drug market is expected to flourish at a robust CAGR
over the forecast period. Moreover, the global diabetic retinopathy drug market is
expected to reach at notable revenue of around USD 705 Million by the end of
2021. The market is expected to expand on the back of increasing incidence of eye
diseases across the globe. Furthermore, increasing number of patients suffering
from diabetes is a major factor which is increasing the occurrence of diabetic
retinopathy which in turn expected to fuel the demand for diabetic retinopathy
drugs in near future.
The North America segment by region accounted for more than 35% market
share of overall diabetic retinopathy drug market in 2015. This growth in North
America can be attributed to increasing prevalence of diabetic retinopathy
amongst the consumers aged 40 and older in United States. Furthermore, the
occurrence rate of diabetic retinopathy for adults in North America is 28.5%.
Increasing Geriatric Population
The world’s geriatric population is continually growing at an unprecedented rate.
Further, high occurrence of diabetes among older population of world is a major
factor which is causing incidence of diabetic retinopathy diseases across the
globe. Apart from this, the occurrence of diabetes is increasing in developed
countries such as United States, Australia and others. Furthermore, increasing
incidence of diabetic retinopathy diseases among geriatric population is a major
factor which is likely to propel the demand for diabetic retinopathy drugs during
the forecast period.
Request For Sample
request/2/rep-id-99
Pages:
https://www.researchnester.com/sample-
Increasing Prevalence of Diabetes
Copyright © Research Nester
www.researchnester.com